Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

This study has been completed.
Information provided by (Responsible Party):
Hoffmann-La Roche Identifier:
First received: April 6, 2005
Last updated: November 2, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
No publications provided by Hoffmann-La Roche

Publications automatically indexed to this study by Identifier (NCT Number):